Consequently, iNKT cell neutralization by humanized anti-CD1d and anti-Vα24Jα18 antibodies has been suggested as a potential therapy for human EoE but no studies on humans been proposed yet. This evidence concerns the gene CD1D and eosinophilic esophagitis.